GSS genetic signatures limited

CHART Thread, page-56

  1. Al.
    231 Posts.
    lightbulb Created with Sketch. 123
    my query is when will the US insurers start to demand improvements in containment noting the incredible costs of the failure to contain this virus, the human costs of 2000 deaths per day implies 4000 ICU patients per day with stays of between 10-40 days - this is a daily compounding cost to insurers or Medicaid of some $400,000,000 - 400 million dollars for the ICU costs. Factor in case positives in the additional spread and at some stage the US are going to have to open their eyes and cost in the value of $125 tests upfront as opposed to outbreaks that have downstream costs of ICU and lengthy hospital stays and likely soon to be stem cell treatments of circa $140k per infusion - the costs is looking in the order of some $1.5 trillion dollars

    a highly specific and sensitive pathology test $25? The value proposition is undeniable. When will GSS get the opportunity to throw the US a lifeline of one of the central tenents of Australian success in containment - accurate & universal / available testing
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $84.04M
Open High Low Value Volume
37.0¢ 37.0¢ 37.0¢ $740 2K

Buyers (Bids)

No. Vol. Price($)
1 27000 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 20000 1
View Market Depth
Last trade - 10.00am 15/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.